Free Trial

MBB Public Markets I LLC Buys New Holdings in The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • MBB Public Markets I LLC acquired a new stake in The Clorox Company, purchasing 2,190 shares valued at approximately $322,000 in the first quarter.
  • The Clorox Company recently increased its quarterly dividend to $1.24 per share, resulting in a dividend yield of 3.9%.
  • Clorox reported earnings of $2.87 per share for the last quarter, surpassing analysts' expectations, with a revenue of $1.99 billion, marking a 4.5% year-over-year increase.
  • Five stocks we like better than Clorox.

MBB Public Markets I LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to its most recent filing with the SEC. The fund acquired 2,190 shares of the company's stock, valued at approximately $322,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Sonora Investment Management Group LLC raised its stake in shares of Clorox by 2.5% during the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock valued at $433,000 after purchasing an additional 72 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Clorox by 0.6% in the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock worth $1,953,000 after acquiring an additional 73 shares during the last quarter. Horizon Investments LLC increased its stake in Clorox by 4.4% in the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock worth $258,000 after acquiring an additional 75 shares during the last quarter. Sfmg LLC increased its stake in Clorox by 2.8% in the 1st quarter. Sfmg LLC now owns 2,780 shares of the company's stock worth $409,000 after acquiring an additional 76 shares during the last quarter. Finally, Hancock Whitney Corp increased its stake in Clorox by 4.3% in the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company's stock worth $304,000 after acquiring an additional 86 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. UBS Group decreased their target price on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research note on Thursday, July 17th. Wells Fargo & Company decreased their target price on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a research note on Friday, September 5th. Morgan Stanley decreased their target price on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. JPMorgan Chase & Co. upped their target price on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research note on Monday, September 8th. Finally, Citigroup restated a "neutral" rating and issued a $135.00 target price (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Reduce" and an average price target of $142.18.

Check Out Our Latest Research Report on CLX

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.57% of the stock is owned by corporate insiders.

Clorox Price Performance

Shares of CLX traded down $0.66 during midday trading on Friday, reaching $123.75. The stock had a trading volume of 1,519,075 shares, compared to its average volume of 1,811,479. The company's 50-day moving average is $124.27 and its 200 day moving average is $132.44. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company has a market capitalization of $15.14 billion, a price-to-earnings ratio of 18.98, a price-to-earnings-growth ratio of 1.00 and a beta of 0.52.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. During the same period in the prior year, the business earned $1.82 EPS. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were issued a dividend of $1.24 per share. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 annualized dividend and a yield of 4.0%. This is a boost from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio (DPR) is currently 76.07%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.